Sökning: WFRF:(Van Gaal W) > (2015) > N-terminal pro-B-ty...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04967naa a2200505 4500 | |
001 | oai:DiVA.org:liu-122778 | |
003 | SwePub | |
008 | 151123s2015 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1227782 URI |
024 | 7 | a https://doi.org/10.1097/ALN.00000000000007282 DOI |
040 | a (SwePub)liu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Potgieter, Danielleu University of KwaZulu Natal, South Africa4 aut |
245 | 1 0 | a N-terminal pro-B-type Natriuretic Peptides Prognostic Utility Is Overestimated in Meta-analyses Using Study-specific Optimal Diagnostic Thresholds |
264 | 1 | b LIPPINCOTT WILLIAMS and WILKINS,c 2015 |
338 | a print2 rdacarrier | |
500 | a Funding Agencies|CLS Behring Biotherapies for Life (Vienna, Austria); Astra Zeneca (Vienna, Austria); Boehringer Ingelheim (Ingelheim, Germany); CLS Behring Biotherapies for Life; Novo Nordisk Pharma GmbH (Vienna, Austria) | |
520 | a Background:N-terminal fragment B-type natriuretic peptide (NT-proBNP) prognostic utility is commonly determined post hoc by identifying a single optimal discrimination threshold tailored to the individual study population. The authors aimed to determine how using these study-specific post hoc thresholds impacts meta-analysis results. Methods: The authors conducted a systematic review of studies reporting the ability of preoperative NT-proBNP measurements to predict the composite outcome of all-cause mortality and nonfatal myocardial infarction at 30 days after noncardiac surgery. Individual patient-level data NT-proBNP thresholds were determined using two different methodologies. First, a single combined NT-proBNP threshold was determined for the entire cohort of patients, and a meta-analysis conducted using this single threshold. Second, study-specific thresholds were determined for each individual study, with meta-analysis being conducted using these study-specific thresholds. Results: The authors obtained individual patient data from 14 studies (n = 2,196). Using a single NT-proBNP cohort threshold, the odds ratio (OR) associated with an increased NT-proBNP measurement was 3.43 (95% CI, 2.08 to 5.64). Using individual study-specific thresholds, the OR associated with an increased NT-proBNP measurement was 6.45 (95% CI, 3.98 to 10.46). In smaller studies (less than100 patients) a single cohort threshold was associated with an OR of 5.4 (95% CI, 2.27 to 12.84) as compared with an OR of 14.38 (95% CI, 6.08 to 34.01) for study-specific thresholds. Conclusions:Post hoc identification of study-specific prognostic biomarker thresholds artificially maximizes biomarker predictive power, resulting in an amplification or overestimation during meta-analysis of these results. This effect is accentuated in small studies. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng |
700 | 1 | a Simmers, Daleu University of KwaZulu Natal, South Africa4 aut |
700 | 1 | a Ryan, Lisau Greys Hospital, South Africa4 aut |
700 | 1 | a Biccard, Bruce M.u University of KwaZulu Natal, South Africa4 aut |
700 | 1 | a Lurati-Buse, Giovanna A.u University of Basel Hospital, Switzerland4 aut |
700 | 1 | a Cardinale, Daniela M.u European Institute Oncol, Italy4 aut |
700 | 1 | a Chong, Carol P. W.u Northern Hospital, Australia; University of Melbourne, Australia4 aut |
700 | 1 | a Cnotliwy, Miloslawu Pomeranian Medical University, Poland4 aut |
700 | 1 | a Farzi, Sylvia I.u Medical University of Graz, Austria4 aut |
700 | 1 | a Jankovic, Radmilo J.u University of Nis, Serbia4 aut |
700 | 1 | a Kwang Lim, Wenu Medical University of Graz, Austria4 aut |
700 | 1 | a Mahla, Elisabethu Medical University of Graz, Austria4 aut |
700 | 1 | a Manikandan, Ramaswamyu Stepping Hill Hospital, England4 aut |
700 | 1 | a Oscarsson, Annau Linköpings universitet,Avdelningen för läkemedelsforskning,Medicinska fakulteten,Region Östergötland, ANOPIVA US4 aut0 (Swepub:liu)annos67 |
700 | 1 | a Phy, Michael P.u Texas Technical University, TX 79430 USA4 aut |
700 | 1 | a Rajagopalan, Sriramu University of Aberdeen, Scotland; Aberdeen Royal Infirm, Scotland4 aut |
700 | 1 | a Van Gaal, William J.u University of Melbourne, Australia4 aut |
700 | 1 | a Waliszek, Mareku M Pirogow Prov Specialist Hospital, Poland4 aut |
700 | 1 | a Rodseth, Reitze N.u University of KwaZulu Natal, South Africa; Cleveland Clin, OH 44106 USA4 aut |
710 | 2 | a University of KwaZulu Natal, South Africab Greys Hospital, South Africa4 org |
773 | 0 | t Anesthesiologyd : LIPPINCOTT WILLIAMS and WILKINSg 123:2, s. 264-271q 123:2<264-271x 0003-3022x 1528-1175 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-122778 |
856 | 4 8 | u https://doi.org/10.1097/ALN.0000000000000728 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.